Insulet (PODD) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Powered by 
Analysis
Insulet (PODD) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | -71.56% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 15.51% |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 68.09% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 34.84% |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | -95.71% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 16.91% |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 55.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.50% |
| Mar 31, 2026 | -13.95% |
| Dec 31, 2025 | -22.74% |
| Sep 30, 2025 | 6.19% |
| Jun 30, 2025 | 24.71% |
| Mar 31, 2025 | 81.51% |
| Dec 31, 2024 | -20.04% |
| Sep 30, 2024 | 34.84% |
| Jun 30, 2024 | 54.53% |
| Mar 31, 2024 | 80.46% |
| Dec 31, 2023 | 488.47% |
| Sep 30, 2023 | 1,571.62% |
| Dec 31, 2019 | -30.33% |
| Sep 30, 2019 | 80.93% |
| Jun 30, 2019 | 67.63% |
| Dec 31, 2018 | 2,161.88% |
| Sep 30, 2018 | 130.68% |
| Jun 30, 2018 | 184.73% |
| Dec 31, 2017 | 85.74% |
| Sep 30, 2017 | -45.55% |